Document is current
Any future updates will be listed below
-
Authors
Ajiboye, Jubilee
Teixeira, José E.
Gasonoo, Makafui
Mattice, Ethan B.
Korwin-Mihavics, Bethany
Miller, Peter
Cameron, Alexandra C.
Stebbins, Erin
Campbell, Scott D.
Griggs, David W.
Spangenberg, Thomas https://orcid.org/0000-0002-5654-8919
Meyers, Marvin J. https://orcid.org/0000-0001-5484-619X
Huston, Christopher D. https://orcid.org/0000-0002-5393-139X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R33 AI141184, R33 AI141184, R33 AI141184)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
- License Information
-
More Information
Article History
Received: 26 September 2023
Accepted: 17 September 2024
First Online: 27 September 2024
Competing interests
: C.D.H., M.J.M., and M.G. are inventors on a pending patent application jointly filed by the University of Vermont and St. Louis University that covers use of pyrazolopyrimidines as anti-infective agents (PCT Application No. 63/504,716 filed May 26, 2023). All other authors declare no competing interests.
